|
|
Science Sparks @ ACTREC
|
8th April 2024 |
Vol. No. 13 ; Issue No.625 |
|
Publications
|
1. Singh AG, Chaturvedi P. (2024) Areca nut and oral cancer. Oral Diseases.
2. Tembhare PR, Sriram H, Khanka T, Gawai S, Bagal B, Ghogale SG, Deshpande N, Girase K, Patil J, Hasan SK, Shetty D, Ghosh K, Chatterjee G, Rajpal S, Patkar NV, Jain H, Punatar S, Gokarn A, Nayak L, Mirgh S, Jindal N, Sengar M, Khattry N, Subramanian PG, Gujral S. Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant. Hemasphere.8(4): e63.
1. Singh AG, Chaturvedi P. (2024) Areca nut and oral cancer. Oral Diseases.
3. Thomas A, Rane SU, Menon S.( 2024) TFE3 rearranged epithelioid hemangioendothelioma of the lymph node: A rare primary presentation of vascular tumor. Indian Journal of Pathology and Microbiology.
4. Singh M, Maitre P, Mody R, Murthy V. (2024) Patterns of failure after prostate-only radiotherapy in high-risk prostate cancer: Implications for refining pelvic nodal contouring guidelines. Clinical Oncology.
|
|
|
|
Video of the Week
|
|
Mobilizing Mathematics for the Fight Against Cancer |
|
|
|
|
|
|
Do You Know?
In 1981, FDA approved the first vaccine against hepatitis B, one of the primary causes of liver cancer.
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|